TA Ventures, ABRT Fund invest $2 mln in Zesty

TA Ventures and ABRT Fund have invested $2 million in Zesty, a UK-based online healthcare booking service. The latest funding round comes on top of a seed funding round from Zesty’s lead investor Mangrove Capital Partners in January 2013. In addition to the funding, Zesty has added to its senior management team, hiring Pam Garside as board advisor, Carl Oliver as UK sales director and Warren Guy as head of product.

Press Release

Zesty, the UK’s leading online healthcare booking service, is today announcing it has closed another round of early stage funding of over $2m from two new international venture capital funds, TA Ventures and ABRT Fund. The latest round of funding is in addition to a large seed investment from lead investor Mangrove Capital Partners in January 2013. The new funding demonstrates a growth of investor confidence in the health tech and digital health market across Europe.
Lloyd Price, Co Founder of Zesty, said: “In 2013 we proved one small Tech startup can improve access to both public & private healthcare markets. Looking forward into 2014, the next 12 months are going to be very exciting. This latest round of funding enables us to diversify away from Dentistry into more lucrative markets. Access to healthcare is a multi billion pound white space of opportunity in the UK and we remain focused on our vision to make booking your next Healthcare appointment as easy as booking a Flight, Hotel or Restaurant online.”

Andrew Gershfeld, Chief Investment Officer for ABRT said: “We are delighted to join our investment partners Mangrove Capital in this latest round of funding for Zesty, we believe online access to healthcare is a huge untapped market in the UK and across Europe. The ABRT team were impressed with the vision and progress the Zesty founders have made and look forward to working with them in 2014 and beyond.” said Andrew Gershfeld, Chief Investment Officer for ABRT.”

In addition to new funding, Zesty has added significant experience to its senior management team with three new hires. Pam Garside joins as Board Advisor, Carl Oliver as UK Sales Director and Warren Guy as Head of Product.

Pam Garside joins Zesty with over 35 years’ experience in the Healthcare sector. She has her own management consultancy, NewHealth, specialising in organisational strategy, is a Fellow of the Judge Business School at the University of Cambridge, Senior Associate of the Nuffield Trust and board member of the International Women’s Forum Leadership Foundation in Washington DC.
Carl Oliver brings 20+ years of sales & account management experience to Zesty following Senior Management roles at Just-Eat, Scoot, Thomson Directories & Yellow Pages. Carl has been responsible for leading & building high performance Sales, Customer Service and Account Management teams in various industries serving the small to medium size enterprise market ranging from online business directories to restaurants, automotive, financial services and healthcare.
Warren Guy brings 15+ years of product & technical experience to Zesty following Senior roles at HealthEngine, CalorieKing, Popfossa & various B2B Startups in Australia and the UK. As one of the first employees at Healthengine.com.au, Warren was instrumental in building Healthengine to become Australia’s leading online healthcare booking service connecting hundreds of thousands of patients and health practitioners every month.
About Zesty:
With Zesty, users can search by location, read ratings and reviews, choose an available appointment and then book online in less than 60 seconds. Zesty launched as a Beta in May 2013 into the UK dental market and has since established itself as a trusted and reliable service for its Beta users.

Zesty is also expanding into new healthcare verticals including physiotherapy, osteopathy, private general practice, facial rejuvenation and dermatology due to high demand from the public.


Zesty Additional Information:
Zesty is the UK’s leading online healthcare appointment booking service backed by Mangrove Capital Partners, TA Ventures and ABRT Fund. Launched in May 2013, Zesty is currently available as a Beta in London, operating in 6 Healthcare markets and plans to expand Nationwide across the UK in 2014 into a total of 25 Healthcare markets.

Zesty’s mission is to make access to Healthcare appointments a lot easier for consumers Zesty’s vision is to make Booking your next Healthcare appointment as easy as booking a Flight, Hotel or Restaurant online

Zesty Investor Information:
Mangrove Capital Partners is an investment firm dedicated to finding and helping passionate, innovative entrepreneurs start and grow global, disruptive companies. With $500 million under management, Mangrove also has the capacity to support its best companies over the long term, by committing significant resources through successive rounds of financing. Mangrove has invested in more than 50 companies such as Brands4friends (sold to eBay), Dialcom, KupiVIP, Nimbuzz, Oktogo, Rdio, Seatwave, SohoOS, Spreets (sold to Yahoo), Wix and Zink. Mangrove also had the privilege of being the first investor in Skype, which was acquired by eBay for over $2.6 billion in 2005.

ABRT Venture Fund is a global investment company with focus in Infrastructure Software, Cloud, Saas, eCommerce and Robotics. ABRT was established by Ratmir Timashev & Andrei Baronov, the founders of Aelita Software, which is known for being sold to a Californian company Quest Software for $115 mil in March 2004. ABRT is also known as the investor in Veeam – global data management and security company and Eastern Europe eCommerce leaders KupiVip, OkToGo, HomeMe.

TA Venture is a venture capital firm focused on investing in innovative seed-stage and early-stage Web companies in the USA, Europe, Ukraine, Russia and other CIS countries. We also invest in growth-stage companies with proven business models that have been successfully implemented in Western markets and which seek to expand their business into Ukraine, Russia and other CIS countries. TA Venture operates a venture capital fund, which has reached an initial capital commitment of $50 million. The company is registered in Luxembourg.